Katja Kaipio
kaanka@utu.fi +358 29 450 4614 +358 50 476 5793 Kiinamyllynkatu 10 Turku |
Publications 
2 of 4
- Melanocortin 3 receptor activation with [D-Trp8]-γ-MSH suppresses inflammation in apolipoprotein E deficient mice (2020)
- European Journal of Pharmacology
(A1 Refereed original research article in a scientific journal) - qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets (2020)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer (2020)
- Clinical Cancer Research
(Other publication) - A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients (2018)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal) - Chemical biology approach to phenotypic intratumor heterogeneity as a source of chemotherapy resistance in high-grade serous ovarian cancer (2018)
- Clinical Cancer Research
(Other publication) - Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines. (2018)
- Clinical Cancer Research
(Other publication) - High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment (2018)
- Clinical Cancer Research
(Other publication) - Identifying differentially methylated sites in samples with varying tumor purity (2018)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth (2017)
- Experimental Cell Research
(A1 Refereed original research article in a scientific journal) - Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells (2017)
- Molecular and Cellular Proteomics
(A1 Refereed original research article in a scientific journal)
UTU Research Portal